Uniting Against Lung Cancer and the National Lung Cancer Partnership Announce Impact Award

Uniting Against Lung Cancer and the National Lung Cancer Partnership Announce Impact Award

Uniting Against Lung Cancer and the National Lung Cancer Partnership have announced that they will be jointly sponsoring the Impact Award, a new $200,000 research grant designed to accelerate the movement of promising ideas in lung cancer research into clinical application. The award is intended to rapidly bring new advances to the clinic and positively impact patient care.

The award is intended to support clinical translational research that will promote significant improvements over current approaches in lung cancer prevention, detection, or therapy. Applicants are expected to demonstrate an ability to produce significant progress for lung cancer patients in the near term. Applicants must present a strategic plan and timeline for clinical implementation within five years of the start of the two-year award period.

At the time of application, the principal investigator must hold a position at or above the level of assistant professor at a not-for-profit sponsoring institutions in the United States. Collaborations with industry partners are encouraged; however, the PI must be an academic researcher.

The award provides funding of $200,000, including a maximum of $18,000 in indirect costs. Grants will be paid over two years at $100,000per year. Grant funds may not be used for tuition, travel, or permanent equipment costs.

Complete program information and application instructions are available at the Uniting Against Lung Cancer Web site.

Contact:
Link to Complete RFP

Primary Subject: Medical Research
Geographic Funding Area: National